Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700021235

Trial Profile

Clinical Trials Insight: 700021235

Phase of Trial: Phase II

Latest Information Update: 17 Mar 2008

At a glance

  • Drugs Omeprazole (Primary)
  • Indications Gastro-oesophageal reflux
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors AGI Therapeutics; Aptalis
  • Most Recent Events

    • 17 Mar 2008 Status changed to completed in accordance with AGI Therapeutics' media release (9086447).
    • 27 Nov 2007 Trial completion expected in the first half of 2008.
    • 01 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top